Your session is about to expire
← Back to Search
Duobrii Lotion for Plaque Psoriasis
Study Summary
This trial will test a new cream for people with mild plaque psoriasis to see if it is safe and effective.
- Plaque Psoriasis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Treatment Group A
- Group 2: Treatment Group B
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are investigators still looking for test subjects?
"That is correct. The clinical trial mentioned is still recruiting patients, as denoted on the website clinicaltrials.gov. This particular study was first posted on 1/17/2022 and edited most recently on 3/8/2022; at present, they are seeking 40 participants from 2 different locations."
Could you briefly touch on the scope of this clinical trial?
"The most recent information on clinicaltrials.gov affirms that this study is still actively looking for patients to enroll. The trial was originally posted on January 17th, 2022 and updated March 8th, of the same year. There are 40 positions available at 2 different sites."
Does this research opportunity have an age limit?
"This specific clinical trial is only for patients aged 18-99. However, there are a total of 32 clinical trials currently underway for minors and 152 different trials involving seniors."
How can I become a subject in this experiment?
"This psoriasis study, which will enroll 40 individuals in total, is seeking out participants that are between 18 and 99 years old."
Are there any harmful side-effects associated with Duobrii 0.01 % / 0.045 % Topical Lotion?
"We believe that Duobrii 0.01 % / 0.045 % Topical Lotion is safe to use based on its Phase 3 status-- meaning there is both some evidence of efficacy and multiple rounds of data supporting safety."
Share this study with friends
Copy Link
Messenger